Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Viridian Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- −9 vs. Q1 2026
- Shares held
- 136.0M
- +23.7M (+21.1%) vs. Q1 2026
- Total value
- $2.50B
- +$288.8M (+13.1%) vs. Q1 2026
- New holders
- 46
- 96 more added
- Sold out
- 55
- 50 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 2,501,869 | $46.0M | 0.00% | +168,656+7.2% | Added |
| Vanguard Portfolio Management LLC | 2,752,827 | $50.6M | 0.00% | +1,111,350+67.7% | Added |
| Wellington Management Group LLP | 3,128,362 | $57.5M | 0.01% | +49,808+1.6% | Added |
| VR Adviser, LLC | 3,257,917 | $59.8M | 1.81% | −624,792−16.1% | Reduced |
| Deep Track Capital, LP | 3,592,740 | $66.0M | 0.97% | +2,198,796+157.7% | Added |
| Vanguard Capital Management LLC | 4,576,860 | $84.1M | 0.00% | +409,659+9.8% | Added |
| Fairmount Funds Management LLC | 5,090,928 | $93.5M | 6.18% | +1,176,470+30.1% | Added |
| Price T Rowe Associates Inc | 5,748,410 | $105.6M | 0.01% | +2,542,375+79.3% | Added |
| State Street Corp | 6,124,976 | $112.5M | 0.00% | +1,452,091+31.1% | Added |
| Kynam Capital Management, LP | 6,453,877 | $118.6M | 6.55% | +4,112,225+175.6% | Added |
| Paradigm Biocapital Advisors LP | 6,723,788 | $123.5M | 2.31% | +3,574,895+113.5% | Added |
| Bellevue Group AG | 6,731,909 | $123.7M | 2.60% | +5,765+0.1% | Added |
| BlackRock, Inc. | 8,551,488 | $157.1M | 0.00% | +720,013+9.2% | Added |
| FMR LLC | 16,604,740 | $305.0M | 0.01% | +1,225,363+8.0% | Added |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −970,018−100.0% | Sold out |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −927,717−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −649,873−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −330,390−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −304,422−100.0% | Sold out |
| Davern Capital Partners, LP | 0 | $0 | 0.00% | −302,457−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −293,308−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −269,587−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −250,401−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −231,270−100.0% | Sold out |
| Propel Bio Management, LLC | 0 | $0 | 0.00% | −210,163−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −166,288−100.0% | Sold out |
| Frontier Capital Management Co LLC | 0 | $0 | 0.00% | −158,371−100.0% | Sold out |
| SEB Asset Management AB | 0 | $0 | 0.00% | −156,957−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −140,595−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −124,257−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −95,235−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −75,200−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −65,080−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −60,815−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −56,231−100.0% | Sold out |
| Kopp Family Office, LLC | 0 | $0 | 0.00% | −55,295−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −54,398−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −52,571−100.0% | Sold out |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0 | $0 | 0.00% | −48,822−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −45,339−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −38,217−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −35,114−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −34,991−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −30,157−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −28,059−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −22,205−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −21,159−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −20,450−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −20,100−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −16,700−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −16,519−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −15,975−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −15,598−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −12,980−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −11,480−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −11,465−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −940−100.0% | Sold out |
| Antipodes Partners Ltd | 0 | $0 | 0.00% | −834−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −511−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −625−100.0% | Sold out |
| Eastern Bank | 0 | $0 | 0.00% | −330−100.0% | Sold out |
| SMA Capital LLC | 0 | $0 | 0.00% | −203−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Rossby Financial, LCC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Stone House Investment Management, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Keating Financial Advisory Services, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |